Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c190c99174dfe46deef72ae3ad792590 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1755eede76ea7e719a3e0d2843cd793 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
filingDate |
2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2b5e1e497550ceae39e52cfae8b343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1839f5143086019bbf512040b67edc07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_554e690ce8e27d341f2cd51ac91e297c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d61de6d7a3f0b8aab416c2afb3e7bc1b |
publicationDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016179962-A |
titleOfInvention |
Formulation containing core-shell structure |
abstract |
Disclosed is a preparation containing a core-shell structure, which has both transdermal absorbability and sustainability, and is excellent in storage stability. A pharmaceutical preparation containing a drug-containing phase containing a core-shell structure in which a core part contains a drug and a shell part contains a surfactant, and the ratio of the core-shell structure to the whole drug-containing phase Is 30% by weight or more. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017119506-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018070535-A |
priorityDate |
2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |